Subscribe to one of our feedsfont size
PrintEditor's Picks
Back « ... 3 4 5 6 7 8 9 10 11 12 13 ... » Next
- Merck Wrote Drug Studies for Doctors
The New York Times - FDA plans to open China office in May
The Associated Press - French Bill Takes Chic Out of Being Too Thin
The New York Times - Big pharma aims to show the drugs still sell
Reuters - Citing Ethics, Some Doctors Are Rejecting Industry Pay
The New York Times - WellPoint developing drug safety monitoring system
Reuters - Testosterone predicts profits on trading floors
Reuters - Sperm and eggs from stem cells 'in 15 years'
The Times - Blood pressure drug reduces bone density in study
Reuters - Co-Payments Go Way Up for Drugs With High Prices
The New York Times - Novartis CEO says further buys are possible -paper
Reuters - Germany relaxes stem cell legislation
AFP - The Dangers in Pre-emption
The New York Times - In U.S., Few Alternatives To Testing On Animals
The Washington Post - Vaccine Safety Panel to Include the Public in Setting Priorities
The Associated Press - On the Retail Frontier, Another Shop in SoHo for the Person Who Has Everything
The New York Times - Inhaled insulin flops, but field may hold promise
Reuters - Big U.S. study links breast cancer to drinking
Reuters - Embryonic Stem Cells' Safety Weighed by FDA
Bloomberg - Lilly, Wyeth Vie for 18 Million Alzheimer's Patients
Bloomberg - Drug protects mice, monkeys from radiation damage
Reuters - Heart ills not to blame for women's poor sex life
Reuters - Amgen Develops Six Cancer Drugs as Anemia Sales
Bloomberg - Takeda to Buy Millennium Pharma for $8.8 Billion
Bloomberg - Pfizer warns of lung cancer link with inhaled insulin
AFP - Roche appeals preliminary anemia drug injunction
Reuters - Biotech chief shifts investment focus
Financial Times - In Shift to Digital, More Repeat Mammograms
The New York Times - French GMO bill passes lower house of parliament
Reuters - Study debunks heart attack-male baldness link
Reuters - Mumps found to have made alarming comeback in U.S.
Reuters - $1 per gallon biofuel touted
The Republican - Cancer drug trials 'being stopped too soon'
Daily Telegraph - FDA cites 62 reports of possible heparin deaths
Reuters - Icahn files suit to gain access to Biogen records
Reuters - Selling Stem Cells
Technology Review - Harnessing Biology, and Avoiding Oil, for Chemical Goods
The New York Times - World food shortages to stay, riots a risk: FAO
Reuters - FDA says Glaxo failed to report Avandia data
Reuters - Kinetic Concepts to Buy LifeCell for $1.7 Billion
Bloomberg - Stem-Cell Studies in People Examined by FDA on Safety
Bloomberg - A Disease That Allowed Torrents of Creativity
The New York Times - India converts failing vaccine plants to testing labs
in-Pharma Technologist - Drug errors hurt 1 in 15 hospitalized kids
MSNBC - Drug Makers Near Old Goal: A Legal Shield
The New York Times - Big pharma drive for UK industry
The Times - Army Is Worried by Rising Stress of Return Tours to Iraq
The New York Times - State bill could ease life science taxes
The Silicon Valley/San Jose Business Journal - Transplanted Brain Cells May Suffer From Parkinson's `Spread'
Bloomberg - JP Morgan bets on large biotechs to beat recession
Reuters - Gene Tests May Be More Confusing Than Illuminating
Bloomberg - Resistant microbe entering hospitals
Reuters - Scientists find host of antibiotic-eating germs
Reuters - State Senate panel OKs bill to label cloned foods
The San Francisco Chronicle - Schering plans $1B cutback as Vytorin, Zetia fall
The Star-Ledger - Lawyers Fight DNA Samples Gained on Sly
The New York Times - Report Claims Clinical Trials Miss Many Populations
HealthDay News - TV drug ads should list FDA hotline, lawmakers say
The Los Angeles Times - 60-Plus, Ripped, and Natural Competitors
The New York Times - China approves bird flu vaccine for humans
Reuters - Research debunks health value of guzzling water
Reuters - Court rejects Patent Office's new rules
Reuters - Reynolds Ads Say Tobacco Oversight Is Burden F.D.A. Doesn't Need
The New York Times - Study Is Setback for Some RNA-Based Drugs
The New York Times - Is Biotech's Health Improving?
Standard & Poors - Scientists create Britain's first hybrid embryos
The Independent - Researchers say gene could help dope cheats
Reuters - Accusations of Delays in Releasing Drug Results
The New York Times - Congress scrutinizes drug ads
Bloomberg - EU's ageing science workforce could damage future innovations
in-Pharma Technologist - Measure could cut biotech funding
Palm Beach Post - Doctors support universal health care: survey
Reuters - ANALYSIS-US may compare medical products; companies wary
Reuters - Seeking Alternatives to Animal-Derived Drugs
The New York Times - Nonprofit gears up for biotech road show
The San Francisco Chronicle - The Drug Scare That Exposed a World of Hurt
The New York Times - Harvard-trained chemist to lead drug maker Eli Lilly
Boston Herald - The Murky Politics of Mind-Body
The New York Times - Good for iPods, but bad for patients
The Boston Globe - FDA Deadlines May Impact Drug Safety
The Associated Press - FDA investigates Merck drug-suicide link
The Associated Press - Wyeth slashing 1,200 sales rep jobs
The Star-Ledger - Momenta, Insmed May Gain From Biotech Generics Law
Bloomberg - Older Americans wealthier, living longer
Reuters - Study Ties Genetic Variations to Schizophrenia
The New York Times - FDA `May Fail' Without More Funds, Agency Chief Says
Bloomberg - Alaska Suit Against Lilly Is Settled
The New York Times - New study urges caution over revolutionary gene treatment
AFP - Scripps starts center focused on stem cells
San Diego Union-Tribune - Genentech's Herceptin May Help Women Who Don't Have Mutant Gene
Bloomberg - Medicare spending triggers new funding proposal
Reuters - Cigarette Company Paid for Lung Cancer Study
The New York Times - Rethinking Is Urged on a Vaccine for AIDS
The New York Times - California Delays Plan to Track Prescription Drugs
The New York Times - UK to force drugmakers to share info
The Associated Press - UN chief urges global fight against TB
The Associated Press - Pfizer Is Denied Access to JAMA Files
The Wall Street Journal - Free drug samples cost more in the long run
MSNBC - Skipping Cereal and Eggs, and Packing on Pounds
The New York Times - Miami doctor breaks new ground in cancer surgery
Reuters
Back « ... 3 4 5 6 7 8 9 10 11 12 13 ... » Next
- Bailout Provides More Mental Health Coverage
The New York Times - Lilly Nears Deal to Buy ImClone
The New York Times - Genetic tests may pinpoint who should get Avastin
Reuters - Top Psychiatrist Didn't Report Drug Makers' Pay
The New York Times - Donating embryos for research may be easier said than done
The Los Angeles Times - NYSE Euronext seen mulling easier biotech IPOs
Guardian - Court affirms Amgen EPO patents, blocks Roche drug
Reuters - Long sick leave for colds signals poor health later: study
Reuters - Strippers, armadillos inspire Ig Nobel winners
Associated Press - More U.S. than European kids take mental health meds
Reuters